Loading...
RAPT Therapeutics, Inc.
RAPT•NASDAQ
Healthcare
Biotechnology
$58.005
$0.00(0.00%)
U.S. Market opens in 34h 17mRAPT Therapeutics, Inc. (RAPT) AI-Powered Stock Analysis
See how RAPT Therapeutics, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerRAPT Therapeutics, Inc. (RAPT) Stock Overall Grade
RAPT Therapeutics, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to RAPT Therapeutics, Inc.'s overall stock rating.
Forecast
AScore
86/100Financial Growth
C+Score
50/100Fundamental Growth
CScore
45/100Key Ratios
C+Score
55/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
BScore
63/100RAPT Therapeutics, Inc. (RAPT) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 86/100 (A), reflecting high confidence in its potential. Financial Growth (50/100, C+) and Fundamental Growth (45/100, C) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (63/100,B) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each RAPT Therapeutics, Inc. stock grade, including financials, comparisons, and forecasts.